Intrust Bank Na Bristol Myers Squibb CO Transaction History

Intrust Bank Na

$978 Million
Q4 2024

A detailed history of Intrust Bank Na transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Intrust Bank Na holds 31,791 shares of BMY stock, worth $2.01 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

31,791

Previous 22,897 38.84%

Holding current value

$2.01 Million

Previous $1.18 Million 51.86%

% of portfolio

0.18%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $461,776 - $533,106	8,894 Added 38.84%	31,791 $1.8 Million
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $123,421 - $161,046	3,112 Added 15.73%	22,897 $1.18 Million
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $177,864 - $234,162	-4,419 Reduced 18.26%	19,785 $821,000
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $109,586 - $124,249	2,284 Added 10.42%	24,204 $1.31 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $78,101 - $93,196	-1,611 Reduced 6.85%	21,920 $1.12 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $153,119 - $171,210	-2,645 Reduced 10.1%	23,531 $1.37 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $239,039 - $265,416	-3,752 Reduced 12.54%	26,176 $1.67 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $55,984 - $63,499	-852 Reduced 2.77%	29,928 $2.07 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $5,204 - $6,162	76 Added 0.25%	30,780 $2.21 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $477 - $282,233	-3,673 Reduced 10.68%	30,704 $2.18 Million
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $224,541 - $247,298	3,092 Added 9.88%	34,377 $2.65 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $528,236 - $633,402	8,592 Added 37.86%	31,285 $2.29 Million
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $15,445 - $18,005	288 Added 1.29%	22,693 $1.42 Million
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $86,624 - $101,469	-1,464 Reduced 6.13%	22,405 $1.33 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $58,628 - $63,846	-947 Reduced 3.82%	23,869 $1.6 Million
Q1 2021 Jun 02, 2021	SELL	$59.34 - $66.74 $266,317 - $299,529	-4,488 Reduced 15.32%	24,816 $1.57 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $64,437 - $73,019	-1,116 Reduced 3.67%	29,304 $1.82 Million
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $12,634 - $14,000	-220 Reduced 0.72%	30,420 $1.83 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $89,740 - $104,915	1,637 Added 5.64%	30,640 $1.8 Million
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $104,956 - $152,526	2,262 Added 8.46%	29,003 $1.62 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $395,697 - $516,151	8,041 Added 43.0%	26,741 $1.72 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $9,666 - $11,460	226 Added 1.22%	18,700 $948,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $86,696 - $95,867	1,943 Added 11.75%	18,474 $838,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $70,206 - $83,712	-1,556 Reduced 8.6%	16,531 $789,000
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $73,237 - $94,971	1,502 Added 9.06%	18,087 $940,000
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $717 - $809	13 Added 0.08%	16,585 $1.03 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $107,932 - $134,525	-2,136 Reduced 11.42%	16,572 $918,000
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $22,649 - $26,074	-378 Reduced 1.98%	18,708 $1.18 Million
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $34,585 - $37,706	-577 Reduced 2.93%	19,086 $1.17 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $1.09 Million - $1.25 Million	19,663	19,663 $1.25 Million

Others Institutions Holding BMY

# of Institutions

2,761

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $134B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account